Growth Metrics

Adaptive Biotechnologies (ADPT) Receivables - Other: 2018-2024

Historic Receivables - Other for Adaptive Biotechnologies (ADPT) over the last 7 years, with Dec 2024 value amounting to $1.3 million.

  • Adaptive Biotechnologies' Receivables - Other rose 15.38% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 15.38%. This contributed to the annual value of $1.3 million for FY2024, which is 30.00% up from last year.
  • According to the latest figures from FY2024, Adaptive Biotechnologies' Receivables - Other is $1.3 million, which was up 30.00% from $1.0 million recorded in FY2023.
  • In the past 5 years, Adaptive Biotechnologies' Receivables - Other registered a high of $1.4 million during FY2021, and its lowest value of $800,000 during FY2022.
  • Over the past 3 years, Adaptive Biotechnologies' median Receivables - Other value was $1.0 million (recorded in 2023), while the average stood at $1.0 million.
  • As far as peak fluctuations go, Adaptive Biotechnologies' Receivables - Other crashed by 62.50% in 2020, and later soared by 55.56% in 2021.
  • Over the past 5 years, Adaptive Biotechnologies' Receivables - Other (Yearly) stood at $900,000 in 2020, then surged by 55.56% to $1.4 million in 2021, then tumbled by 42.86% to $800,000 in 2022, then rose by 25.00% to $1.0 million in 2023, then skyrocketed by 30.00% to $1.3 million in 2024.